DIRECTLY COMPRESSIBLE MATRIX FOR CONTROLLED RELEASE OF SINGLE DAILY DOSES OF CLARITHROMYCIN

Farmaceutska formulacija za kontrolirano odpustanje za peroralnu jednostruku dnevnu primjenu, naznacena time, da sadrzi klaritromicin i smjesu masne i hidrofilne komponente. Patent sadrzi jos 14 patentnih zahtjeva. The invention refers to an improved pharmaceutical formulation for controlled release...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MILOJKA MOHAR, DARJA FERCEJ TEMELJOTOV, LJUBOMIRA BARBARA REBIC, MARKO OPRESNIK, MATEJA SALOBIR
Format: Patent
Sprache:hrv ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Farmaceutska formulacija za kontrolirano odpustanje za peroralnu jednostruku dnevnu primjenu, naznacena time, da sadrzi klaritromicin i smjesu masne i hidrofilne komponente. Patent sadrzi jos 14 patentnih zahtjeva. The invention refers to an improved pharmaceutical formulation for controlled release of clarithromycin or its derivatives, enabled by a novel combined matrix consisting of a fatty and a hydrophilic component, whereto also a surfactant and a pH-modulator may be added when an additional influence on the release profile of the active substance is desired.